Kia Mataara: feasibility of remote surveillance to stay alert for lung cancer.

Not Applicable

• Conditions: lung cancer; Cancer - Lung - Mesothelioma; Cancer - Lung - Non small cell; Cancer - Lung - Small cell

• Registration Number: ACTRN12621000155897
• Lead Sponsor: niversity of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-02-15
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Inclusion criteria
Patients over 18 years of age with confirmed non-small cell lung cancer stage 3b (non-curative intent) and stage 4, small cell lung cancer patients, and patients with mesothelioma.
Participants must have competency to sign consent.
Patients must have completed standard of care systemic treatment for their cancer.
Patients must have an ECOG performance status of 0 -3

Exclusion Criteria

Patients with an EGFR or ALK mutation on Tyrosine Kinase Inhibitor therapy.
Patients on systemic treatments including maintenance chemotherapy or immunotherapy.
Patients who are progressing to palliative radiotherapy treatment.
All non-English speaking patients who would require an interpreter.

Study & Design

• Study Type: Interventional
• Study Design: Not specified